Optimising treatment decisions: personalising ATTR-CM treatment in real-world practice

28 August 2026 (13:10 - 13:28)

Organised by:

Slides

Sign in to view the resources

About the speakers

Doctor Sarah Cuddy

Brigham and Women's Hospital, Boston (United States of America)

Doctor Pablo Garcia-Pavia

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Spain)

4 More presentations in this session

Presentation thumbnail

Introduction

Professor C. Tschoepe (Berlin, DE)

Presentation thumbnail

Optimising treatment decisions: why speed of effect matters in ATTR-CM

Doctor L. Obici (Pavia, IT) Professor C. Tschoepe (Berlin, DE)

Presentation thumbnail

Optimising treatment decisions: the clinical relevance of strength of effect in ATTR-CM

Doctor L. Obici (Pavia, IT) Doctor J. Gillmore (Greater London, GB)

Presentation thumbnail

Closing remarks

Professor C. Tschoepe (Berlin, DE)

Access the full session

Session thumbnail

Then and now: reflections on the transformation of ATTR-CM care

The Event

Event poster

ESC Congress 2026

28 August 2026 13:10 CET

You may be interested in

Congress Session

Idiopathic heart failure or undiagnosed ATTR-CM? Making an early and accurate diagnosis

27 August 2022

Congress Presentation

How do long-term data inform real-world decisions in ATTR-CM?

29 August 2026

Congress Presentation

Multisystem clues leading to the diagnosis of hereditary transthyretin amyloidosis: non-biopsy confirmation and early detection through family screening

28 August 2026

Congress Session

Time matters in transthyretin amyloid cardiomyopathy (ATTR-CM): emerging artificial intelligence approaches to screening and clinical considerations for treatment timing

28 August 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources